Carfilzomib-induced nephrotoxcity

被引：4
|
作者：
Jhaveri, Kenar D. [1 ]
Wanchoo, Rimda [1 ]
机构：
[1] Hofstra North Shore LIJ Sch Med, Div Kidney Dis & Hypertens, Great Neck, NY USA
来源：
KIDNEY INTERNATIONAL | 2015年 / 88卷 / 01期
关键词：
D O I：
10.1038/ki.2015.133
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：199 / 200
页数：4
相关论文
共 50 条
  • [21] Carfilzomib-induced life-threatening lung injury in refractory multiple myeloma
    Ghasoub, Rola
    Benkhadra, Maria
    Kassem, Nancy
    Alshurafa, Awni
    Elsabah, Hesham
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (08) : 2041 - 2044
  • [22] Investigating the molecular mechanisms of carfilzomib-induced cardiotoxicity and the emerging role of metformin as a prophylactic therapy
    Kremastiotis, G.
    Efentakis, P.
    Varela, A.
    Davos, C. H.
    Papanagnou, E. -D.
    Trougakos, I. P.
    Kastritis, E.
    Kanaki, Z.
    Iliodromitis, E. K.
    Klinakis, A.
    Dimopoulos, M. A.
    Terpos, E.
    Andreadou, I.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1003 - 1003
  • [23] Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review
    Meseha, Mina
    Qu, Dan
    Lykon, Jill
    Coffey, David
    ANNALS OF HEMATOLOGY, 2024, 103 (10) : 4313 - 4317
  • [24] Carfilzomib-Induced Tumor Lysis Syndrome and Biventricular Heart Failure in a Patient With Multiple Myeloma
    Azad, Farhan
    Moyer, Ross
    Miranda, Clive J.
    Gravina, Matthew
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [25] Carfilzomib-induced tumor lysis syndrome in relapsed multiple myeloma: a report of two cases
    Demirsoy, Esra Terzi
    Atesoglu, Elif Birtas
    Eren, Necmi
    Geduk, Ayfer
    Mehtap, Ozgur
    Tarkun, Pinar
    Hacihanefioglu, Abdullah
    TUMORI JOURNAL, 2019, 105 (06): : NP24 - NP27
  • [26] Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma
    Rassner, Michael
    Baur, Rebecca
    Waesch, Ralph
    Schiffer, Mario
    Schneider, Johanna
    Mackensen, Andreas
    Engelhardt, Monika
    BMC NEPHROLOGY, 2021, 22 (01)
  • [27] Mineralocorticoid Receptor Pathway Is a Key Mediator of Carfilzomib-induced Nephrotoxicity: Preventive Role of Eplerenone
    Efentakis, Panagiotis
    Lamprou, Sofia
    Makridakis, Manousos
    Barla, Ioanna
    Nikolaou, Panagiota-Efstathia
    Christodoulou, Andriana
    Dimitriou, Costantinos
    Kostomitsopoulos, Nikolaos
    Ntanasis-Stathopoulos, Ioannis
    Theochari, Irene
    Gavriatopoulou, Maria
    Gakiopoulou, Harikleia
    Tasouli, Androniki
    Vlahou, Antonia
    Gikas, Evangelos
    Thomaidis, Nikolaos
    Dimopoulos, Meletios-Athanasios
    Terpos, Evangelos
    Andreadou, Ioanna
    HEMASPHERE, 2022, 6 (11): : E791
  • [28] Case Report: Carfilzomib-induced Thrombotic Microangiopathy With Complement Activation Treated Successfully With Eculizumab
    Bhutani, Divaya
    Assal, Amer
    Mapara, Markus Y.
    Prinzing, Samantha
    Lentzsch, Suzanne
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (04): : E155 - E157
  • [29] Inhibition of autophagy with chloroquine potentiates carfilzomib-induced apoptosis in myeloma cells in vitro and in vivo
    Jarauta, Vidal
    Jaime, Paula
    Gonzalo, Oscar
    de Miguel, Diego
    Ramirez-Labrada, Ariel
    Martinez-Lostao, Luis
    Anel, Alberto
    Pardo, Julian
    Marzo, Isabel
    Naval, Javier
    CANCER LETTERS, 2016, 382 (01) : 1 - 10
  • [30] Carfilzomib-induced reticulocytosis in patients with multiple myeloma is caused by impaired terminal erythroid maturation
    Nicolas G. Kint
    Elien Heylen
    Daniele Pepe
    Kim De Keersmaecker
    Catherine M. Verfaillie
    Michel Delforge
    Leukemia, 2020, 34 : 651 - 655
12345